BIOA
Bioage Labs Announces Multi-Year Collaboration With Novartis to Discover Novel Targets for Therapies That Address Age-Related Diseases and Conditions
时间：2024-12-18 22:00:03 市场： 美股 综合
Bioage Labs Falls 76.9% After Jefferies Cuts PT on Co
时间：2024-12-09 22:37:23 市场： 综合 美股
Bioage Labs Announces Discontinuation of Strides Phase 2 Clinical Trial Evaluating Azelaprag in Combination With Tirzepatide for the Treatment of Obesity
时间：2024-12-07 05:35:19 市场： 美股 综合
Bioage Labs Inc - Decision Follows Observations of Liver Transaminitis Without Clinically Significant Symptoms in Some Subjects on Azelaprag
时间：2024-12-07 05:35:19 市场： 美股 综合
Bioage Labs Inc - No Transaminase Elevations in Tirzepatide Only Group
时间：2024-12-07 05:35:19 市场： 美股 综合
Bioage Labs Inc - Dosing Discontinued, No Additional Subjects to Be Enrolled
时间：2024-12-07 05:35:19 市场： 美股 综合
Bioage Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
时间：2024-11-08 05:30:01 市场： 美股 综合
Bioage Labs Inc : Citigroup Initiates Coverage With Buy Rating; Target Price $45
时间：2024-10-22 18:51:53 市场： 美股 综合
Bioage Labs Shares Open at $22.50 in Nasdaq Debut VS $18 IPO Price
时间：2024-09-27 00:14:47 市场： 美股 综合